Exploration in the mechanism of fucosterol for the treatment of non-small cell lung cancer based on network pharmacology and molecular docking
Xiaoling Li(Southwestern Medical Center), Lianxiang Luo(Guangdong Medical College)
Cited by 30
Related Papers
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer
|Cancer Cell|2023|47
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
|Cancer Cell International|2020|42
Exploring the mechanism of astaxanthin against lipopolysaccharide-induced acute lung injury by network pharmacology and experimental validation
|Research Square|2021|2
Sodium glucose co-transporter 2 inhibitor empagliflozin prevents endothelial dysfunction induced by oscillatory shear stress
|Biomedicine & Pharmacotherapy|2025|2